🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study seeks to investigate safety and efficacy of ixazomib (NINLARO), a...
Status
Recruiting
Location
Royal London Hospital, Barts Health NHS Foundation Trust
Start Date
2020-06-15
Trial ID
NCT03783416
Treatments Being Tested
The primary purpose of this study is to determine the overall response rate...
Status
Withdrawn
Location
CEHON Centro de Hematologia e Oncologia da Bahia
Start Date
2019-09-30
Trial ID
NCT03608501
Treatments Being Tested
The purpose of this study is to determine whether the addition of oral ixaz...
Status
Completed
Location
University of Arkansas Medical Sciences
Start Date
2012-08-01
Trial ID
NCT01564537
Treatments Being Tested
This study will determine the safety profile, tolerability, and maximum tol...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-10-12
Trial ID
NCT00932698
Treatments Being Tested
The purpose of this study is to provide continued access of ixazomib and/or...
Status
Terminated
Location
Cedars Sinai Medical Center
Start Date
2012-12-26
Trial ID
NCT01659658
Treatments Being Tested
This is a phase 1, 2-part, pharmacokinetic study in patients with advanced ...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01912222
Treatments Being Tested
The purpose of this research study is to learn about the effects of the med...
Status
Terminated
Location
Mayo Clinic in Arizona
Start Date
2021-04-28
Trial ID
NCT04837131
Treatments Being Tested
This is a randomized, Phase 2 study involving two arms evaluating the effic...
Status
Terminated
Location
James R Berenson, MD, Inc.
Start Date
2019-03-01
Trial ID
NCT03733691
Treatments Being Tested
Allogeneic hematopoietic stem cell transplantation (HTC) is the only curati...
Status
Unknown
Location
ICO- Hospital Germans Trias i Pujol
Start Date
2017-05-16
Trial ID
NCT03225417
Treatments Being Tested
The purpose of this study is to characterize the safety and tolerability of...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06-09
Trial ID
NCT02176486